Product Name :
CHR-6494
Description:
CHR-6494 is a potent and selective histone kinase Haspin inhibitor. CHR-6494 reduces H3T3ph levels in a dose-dependent manner and causes a mitotic catastrophe characterized by metaphase misalignment, spindle abnormalities and centrosome amplification. CHR-6494 shows antitumor potential in xenografted nude mice without any observed toxicity. Thus, CHR-6494 is a first-in-class Haspin inhibitor with a wide spectrum of anticancer effects that merits further preclinical research as a new member of the family of mitotic kinase inhibitors.
CAS:
1333377-65-3
Molecular Weight:
292.34
Formula:
C16H16N6
Chemical Name:
3-(1H-indazol-5-yl)-N-propylimidazo[1,2-b]pyridazin-6-amine
Smiles :
CCCNC1C=CC2=NC=C(C3C=C4C=NNC4=CC=3)N2N=1
InChiKey:
CZZCAOGIEGXMBZ-UHFFFAOYSA-N
InChi :
InChI=1S/C16H16N6/c1-2-7-17-15-5-6-16-18-10-14(22(16)21-15)11-3-4-13-12(8-11)9-19-20-13/h3-6,8-10H,2,7H2,1H3,(H,17,21)(H,19,20)
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.{{Fianlimab} site|{Fianlimab} LAG-3|{Fianlimab} Protocol|{Fianlimab} In Vitro|{Fianlimab} manufacturer|{Fianlimab} Autophagy}
Shelf Life:
≥360 days if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
CHR-6494 is a potent and selective histone kinase Haspin inhibitor. CHR-6494 reduces H3T3ph levels in a dose-dependent manner and causes a mitotic catastrophe characterized by metaphase misalignment, spindle abnormalities and centrosome amplification. CHR-6494 shows antitumor potential in xenografted nude mice without any observed toxicity.{{GM-CSF Protein, Mouse} web|{GM-CSF Protein, Mouse} Protocol|{GM-CSF Protein, Mouse} In stock|{GM-CSF Protein, Mouse} supplier|{GM-CSF Protein, Mouse} Autophagy} Thus, CHR-6494 is a first-in-class Haspin inhibitor with a wide spectrum of anticancer effects that merits further preclinical research as a new member of the family of mitotic kinase inhibitors.PMID:32695810 |Product information|CAS Number: 1333377-65-3|Molecular Weight: 292.34|Formula: C16H16N6|Chemical Name: 3-(1H-indazol-5-yl)-N-propylimidazo[1,2-b]pyridazin-6-amine|Smiles: CCCNC1C=CC2=NC=C(C3C=C4C=NNC4=CC=3)N2N=1|InChiKey: CZZCAOGIEGXMBZ-UHFFFAOYSA-N|InChi: InChI=1S/C16H16N6/c1-2-7-17-15-5-6-16-18-10-14(22(16)21-15)11-3-4-13-12(8-11)9-19-20-13/h3-6,8-10H,2,7H2,1H3,(H,17,21)(H,19,20)|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥360 days if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|Products are for research use only. Not for human use.|